The controls of microvascular survival

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 75-81

  Benjamin, L E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Apoptosis; Endothelial cell; Pericyte; Survival; VEGF A

Indexed keywords

THALIDOMIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL SURVIVAL; COMPLEX FORMATION; ENDOTHELIUM CELL; HYPOXIA; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; TARGET CELL; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0034532027     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026552415576     Document Type: Review

References (66)

1. Mechanism of action in thalidomide teratogenesis
2. Vascular endothelial growth factor (VEGF) and its receptors
3. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
4. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
5. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
6. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
7. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
8. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
9. Vaso-obliteration in the canine model of oxygen-induced retinopathy
10. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
11. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina
12. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
13. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy
14. Molecular mechanisms of vascular permeability in diabetic retinopathy
15. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox
16. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
17. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
18. Blood vessel maturation: Vascular development comes of age
19. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
20. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
21. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
22. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice
23. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
24. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
25. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
26. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
27. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
28. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
29. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
30. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
31. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
32. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
33. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells
34. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
35. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells
36. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
37. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
38. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
39. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation
40. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
41. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
42. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells
43. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappa B in human endothelial cells
44. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway
45. VEGF upregulates ICAM-1 expression via the PI3K/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells
46. The Akt kinase signals directly to endothelial nitric oxide synthase
47. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis
48. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2- dependent and independent mechanisms
49. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl- 2 expression
50. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
51. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
52. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
53. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: Involvement in suppression of apoptosis
54. Distinct mechanical stimuli differentially regulate the PI3K/Akt survival pathway in endothelial cells
55. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro
56. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques
57. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002
58. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
59. Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress
60. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
61. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis
62. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
63. Endothelial progenitor cells as putative targets for angiostatin
64. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
65. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
66. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth